sublocade
Generic: buprenorphine extended-release
sublocade: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | Phase 4 |
Clinical Trials (1)
An Open-label, Rapid Initiation Study for Extended-Release Buprenorphine Subcutaneous Injection (SUBLOCADE)
Frequently asked questions
Who is developing sublocade?
sublocade is being developed by Indivior Pharmaceuticals, Inc..
How many clinical trials involve sublocade?
BioSniper tracks 1 clinical trial involving sublocade.
Get deeper analysis on sublocade
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis